Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Kalra

Showing results (421-430 of 486) with videos related to

Pageof 49
Sort By:
JMIR Formative Research|April 16, 2026
A Digital Inclusion Intervention to Improve Access to a Digital Health Intervention Among Digitally Excluded Adults: Mixed Methods Pilot Randomized Controlled TrialChristy Walklin, Juliet Briggs, Siobhan Freeman, et al.
Science Signaling|March 3, 2021
SOX9 is required for kidney fibrosis and activates NAV3 to drive renal myofibroblast functionSayyid Raza, Elliot Jokl, James Pritchett, et al.
Kidney International Reports|August 15, 2022
An Analysis of Vascular Access Thrombosis Events From the Proactive IV irOn Therapy in hemodiALysis Patients TrialPeter C Thomson, Patrick B Mark, Michele Robertson, et al.
Journal of the American Society of Nephrology : JASN|April 8, 2020
Intravenous Iron Dosing and Infection Risk in Patients on Hemodialysis: A Prespecified Secondary Analysis of the PIVOTAL TrialIain C Macdougall, Sunil Bhandari, Claire White, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|December 21, 2010
Protection Against Nephropathy in Diabetes with Atorvastatin (PANDA): a randomized double-blind placebo-controlled trial of high- vs. low-dose atorvastatin(1)M K Rutter, H R Prais, V Charlton-Menys, et al.
Clinical Kidney Journal|January 15, 2025
Iron management and exercise training in individuals with chronic kidney disease: lived experiencesCourtney J Lightfoot, Sharlene A Greenwood, Elham Asgari, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 4, 2016
Effect of renal artery revascularization upon cardiac structure and function in atherosclerotic renal artery stenosis: cardiac magnetic resonance sub-study of the ASTRAL trialJames Ritchie, Darren Green, Tina Chrysochou, et al.
Journal of Clinical Medicine|February 27, 2026
Expert Perspectives on Managing Iron Deficiency in People with CKD and/or HFSunil Bhandari, John G F Cleland, Fozia Z Ahmed, et al.
Health Technology Assessment (Winchester, England)|June 23, 2020
Sodium bicarbonate to improve physical function in patients over 60 years with advanced chronic kidney disease: the BiCARB RCTMiles D Witham, Margaret Band, Huey Chong, et al.
Circulation|July 14, 2018
Effects of Sacubitril/Valsartan Versus Irbesartan in Patients With Chronic Kidney DiseaseRichard Haynes, Parminder K Judge, Natalie Staplin, et al.
Pageof 49

Showing results (421-430 of 486) with videos related to

Sort By:
Pageof 49
JMIR Formative Research|April 16, 2026
A Digital Inclusion Intervention to Improve Access to a Digital Health Intervention Among Digitally Excluded Adults: Mixed Methods Pilot Randomized Controlled TrialChristy Walklin, Juliet Briggs, Siobhan Freeman, et al.
Science Signaling|March 3, 2021
SOX9 is required for kidney fibrosis and activates NAV3 to drive renal myofibroblast functionSayyid Raza, Elliot Jokl, James Pritchett, et al.
Kidney International Reports|August 15, 2022
An Analysis of Vascular Access Thrombosis Events From the Proactive IV irOn Therapy in hemodiALysis Patients TrialPeter C Thomson, Patrick B Mark, Michele Robertson, et al.
Journal of the American Society of Nephrology : JASN|April 8, 2020
Intravenous Iron Dosing and Infection Risk in Patients on Hemodialysis: A Prespecified Secondary Analysis of the PIVOTAL TrialIain C Macdougall, Sunil Bhandari, Claire White, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|December 21, 2010
Protection Against Nephropathy in Diabetes with Atorvastatin (PANDA): a randomized double-blind placebo-controlled trial of high- vs. low-dose atorvastatin(1)M K Rutter, H R Prais, V Charlton-Menys, et al.
Clinical Kidney Journal|January 15, 2025
Iron management and exercise training in individuals with chronic kidney disease: lived experiencesCourtney J Lightfoot, Sharlene A Greenwood, Elham Asgari, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 4, 2016
Effect of renal artery revascularization upon cardiac structure and function in atherosclerotic renal artery stenosis: cardiac magnetic resonance sub-study of the ASTRAL trialJames Ritchie, Darren Green, Tina Chrysochou, et al.
Journal of Clinical Medicine|February 27, 2026
Expert Perspectives on Managing Iron Deficiency in People with CKD and/or HFSunil Bhandari, John G F Cleland, Fozia Z Ahmed, et al.
Health Technology Assessment (Winchester, England)|June 23, 2020
Sodium bicarbonate to improve physical function in patients over 60 years with advanced chronic kidney disease: the BiCARB RCTMiles D Witham, Margaret Band, Huey Chong, et al.
Circulation|July 14, 2018
Effects of Sacubitril/Valsartan Versus Irbesartan in Patients With Chronic Kidney DiseaseRichard Haynes, Parminder K Judge, Natalie Staplin, et al.
Pageof 49